Articles Referencing SLXP
Positive Data from Synergy Pharma - Analyst Blog
5/24/2013, 12:29 pm from Zacks.com in Investing, Business, Stocks
Synergy Pharmaceuticals Inc. ( SGYP ) recently announced positive results from a
multicenter trial which evaluated its pipeline candidate
plecanatide for treating patients suffering from... Read >>
New Diagnostic Solution from Roche - Analyst Blog
5/24/2013, 11:25 am from Zacks.com in Investing, Business, Stocks
Roche ( RHHBY ) recently
announced that it intends to introduce a fully automated lab
solution - cobas 8100 workflow series - shortly. Cobas 8100 is a new diagnostic solution from Roche,... Read >>
Pfizer Halts Inotuzumab Study - Analyst Blog
5/23/2013, 7:27 pm from Zacks.com in Investing, Business, Stocks
Pfizer Inc. ( PFE ) recently faced a
pipeline setback with the company discontinuing a late-stage study
being conducted with its oncology candidate, inotuzumab
ozogamicin. The randomized,... Read >>
Repros to Conduct Phase IIb Trial - Analyst Blog
5/23/2013, 6:30 pm from Zacks.com in Investing, Business, Stocks
Recently, the US Food and Drug Administration (FDA) recommended
Repros Therapeutics Inc. ( RPRX ) to conduct a
phase IIb trial on its pipeline candidate, Proellex-V before
commencing phase... Read >>
Data on AstraZeneca's Naloxegol - Analyst Blog
5/23/2013, 6:28 pm from Zacks.com in Investing, Business, Stocks
AstraZeneca ( AZN ) recently
presented data on naloxegol (25 mg once daily) from two pivotal
phase III studies (KODIAC-04 and -05) at the Digestive Disease Week
(DDW) meeting. Top-line... Read >>
Positive Data on Roche Candidate - Analyst Blog
5/22/2013, 6:28 pm from Zacks.com in Investing, Business, Stocks
Roche ( RHHBY ) recently
announced positive data on its ulcerative colitis (UC) candidate,
etrolizumab (RG7413), from EUCALYPTUS, a phase II induction study
(n=124). The study is... Read >>
Data on UCB's Neupro - Analyst Blog
5/22/2013, 5:27 pm from Zacks.com in Investing, Business, Stocks
UCB ( UCBJF ) recently
presented data from a study showing the effect of Neupro on
cardiovascular measures in patients with restless legs syndrome
(RLS). The double-blind,... Read >>
Data on Merck KGaA's L-BLP25 - Analyst Blog
5/22/2013, 5:26 pm from Zacks.com in Investing, Business, Stocks
Merck KGaA ( ">MKGAF
) recently presented detailed results on its oncology candidate
L-BLP25, from the phase III study, START ( S
timulating T argeted A ntigenic
R ... Read >>
AbbVie Extends Galapagos Deal - Analyst Blog
5/22/2013, 11:27 am from Zacks.com in Investing, Business, Stocks
AbbVie ( ABBV ) and biotech
company, Galapagos NV, recently extended their agreement for the
development of autoimmune disease candidate, GLP0634. The original
agreement, announced in Feb... Read >>
Positive Data on Novo Nordisk's N9-GP - Analyst Blog
5/21/2013, 5:27 pm from Zacks.com in Investing, Business, Stocks
Novo Nordisk ( NVO ) recently
announced positive phase III data on its hemophilia B candidate,
N9-GP, from the paradigm 2 study. Paradigm 2 evaluated N9-GP, a long-acting FIX derivative,... Read >>
Actavis to Buy Warner Chilcott - Analyst Blog
5/21/2013, 4:25 pm from Zacks.com in Investing, Business, Stocks
Actavis, Inc. ( ACT ) recently
announced its intention to acquire Warner Chilcott
plc ( WCRX
) in a stock-for-stock transaction worth about $8.5 billion. This
includes the assumption of... Read >>
JNJ's Simponi Label Expanded - Analyst Blog
5/21/2013, 11:26 am from Zacks.com in Investing, Business, Stocks
Johnson & Johnson's ( JNJ ) recently gained
approval from the US Food and Drug Administration (FDA) for the
expansion of Simponi's label. The FDA granted Simponi approval for
the... Read >>
FDA Accepts Actavis NDA - Analyst Blog
5/20/2013, 12:05 pm from Zacks.com in Investing, Business, Stocks
The US Food and Drug Administration (FDA) recently accepted
Actavis, Inc.'s ( ACT ) new drug
application for its oral contraceptive candidate. The company is
looking to get its... Read >>
Good News for Roche's Tarceva - Analyst Blog
5/16/2013, 6:27 pm from Zacks.com in Investing, Business, Stocks
Roche ( RHHBY ) recently
announced that the US Food and Drug Administration (FDA) has
approved Tarceva (erlotinib) tablets for the first line treatment
of patients suffering from metastatic... Read >>
Good News for Novartis' Ilaris - Analyst Blog
5/15/2013, 6:29 pm from Zacks.com in Investing, Business, Stocks
Novartis ( NVS ) recently
announced that the US Food and Drug Administration (FDA) has
approved Ilaris (canakinumab) for an additional indication.
Ilaris is now approved for the... Read >>